| S2198 |
SGI-1776 free base
|
SGI-1776 free base is a novel ATP competitive inhibitor of Pim1 with IC50 of 7 nM in a cell-free assay, 50- and 10-fold selective versus Pim2 and Pim3, also potent to Flt3 and haspin. SGI-1776 induces apoptosis and autophagy. |
-
Cell Death Dis, 2024, 15(9):644
-
Mar Drugs, 2024, 22(10)444
-
Mol Cancer, 2023, 22(1):64
|
|
| S7104 |
AZD1208
|
AZD1208 is a potent, and orally available Pim kinase inhibitor with IC50 of 0.4 nM, 5 nM, and 1.9 nM for Pim1, Pim2, and Pim3 in cell-free assays, respectively. AZD1208 induces autophagy, cell cycle arrest and apoptosis. Phase 1. |
-
Nat Commun, 2025, 16(1):256
-
Angiogenesis, 2024, 10.1007/s10456-024-09906-y
-
Cell Death Dis, 2024, 15(4):274
|
|
| S7985 |
PIM447 (LGH447) Hydrochloride
|
PIM447 (LGH447) Hydrochloride is a novel pan-PIM kinase inhibitor with Ki values of 6 pM, 18 pM, 9 pM for PIM1, PIM2, PIM3 respectively. It also inhibits GSK3β, PKN1, and PKCτ, but at a significantly lower potency with IC50 between 1 and 5 μM (>105-fold differential relative to the Ki on PIMs). PIM447 induces apoptosis. |
-
Oncogene, 2024, 43(6):406-419
-
NPJ Precis Oncol, 2024, 8(1):152
-
Antiviral Res, 2024, 226:105891
|
|
| S8005 |
SMI-4a
|
SMI-4a (TCS PIM-1 4a) is a potent inhibitor of Pim1 with IC50 of 17 nM, modestly potent to Pim-2, does not significantly inhibit any other serine/threonine- or tyrosine-kinases. |
-
Transl Gastroenterol Hepatol, 2024, 9:14
-
J Transl Med, 2023, 21(1):452
-
Nat Commun, 2022, 13-1:5866
|
|
| S7041 |
CX-6258 HCl
|
CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.
|
-
Elife, 2023, 12e69521
-
Nat Med, 2020, 10.1038/s41591-020-0926-0
-
Nat Commun, 2020, 29;11(1):2086
|
|
| S8800 |
Uzansertib (INCB053914)
|
Uzansertib (INCB053914) is a novel, ATP-competitive, small molecule, pan-inhibitor of PIM kinases with IC50 values of 0.24 nM, 30 nM and 0.12 nM for PIM1, PIM2 and PIM3 respectively in biochemical assays. |
-
Antiviral Res, 2024, 226:105891
-
Cancer Lett, 2020, 476:23-33
-
Fish Shellfish Immunol, 2020, 99:86-98
|
|
| S6774 |
TP-3654
|
TP-3654 is the second-generation PIM inhibitor with Ki values of 5 nM, 239 nM, and 42 nM for PIM-1, PIM-2 and PIM-3, respectively. |
-
Cancer Lett, 2025, 613:217496
-
PLoS One, 2023, 10.1371/journal.pone.0294065
-
Int J Mol Sci, 2021, 22(17)9440
|
|
| S3296 |
Hispidulin
|
Hispidulin (Dinatin), an active natrual ingredient in a number of traditional Chinese medicinal herbs, exhibits inhibitory activity against the oncogenic protein kinase Pim-1 with IC50 of 2.71 μM. Hispidulin induces apoptosis through mitochondrial dysfunction and inhibition of P13k/Akt signalling pathway in HepG2 cancer cells. Hispidulin exerts anti-osteoporotic and bone resorption attenuating effects via activating the AMPK signaling pathway. |
-
Evid Based Complement Alternat Med, 2023, 2023:9428241
|
|
| S6497 |
SMI-16a
|
SMI-16a is a selective Pim kinase inhibitor with IC50 values of 150 nM and 20 nM for Pim1 and Pim2 respectively. |
-
J Cell Physiol, 2022, 10.1002/jcp.30814
|
|
| F0857 |
Pim-1 Antibody [C2K23]
|
Pim-1 Rabbit mAb recognizes endogenous levels of total Pim-1 protein. No cross reactivity was detected with other Pim family members. |
|
|
| F0808 |
Pim-3 Antibody [H6L6]
|
Pim-3 Rabbit mAb detects endogenous levels of total Pim-3 protein. It does not cross-react with other Pim family members. |
|
|
| F0754 |
Pim-2 Antibody [J4J24]
|
|
|
|
| E4598 |
MEN1703(SEL24,SEL24-B489)
|
MEN1703(SEL24-B489,SEL24, Pim/flt3 kinase inhibitor SEL24) is a potent, type I, orally active, dual inhibitor of PIM and FLT3-ITD, that exhibits Kd values of 2 nM for PIM1, 2 nM for PIM2 and 3 nM for PIM3, respectively. MEN1703 exhibits its broad therapeutic potential in treatment of acute myeloid leukemia. |
|
|
| S1050 |
TCS PIM-1 1
|
TCS PIM-1 1 (SC 204330) is a potent and selective inhibitor of ATP-competitive Pim-1 kianse with IC50 of 50 nM, shows good selectivity over Pim-2 and MEK1/MEK2 with IC50 > 20000 nM. |
|
|
| E0675 |
Quercetagetin
|
Quercetagetin (6-Hydroxyquercetin), a flavonoid, is a moderately potent and selective, cell-permeable Pim-1 kinase inhibitor with IC50 of 0.34 μM. |
|
|
| S2198 |
SGI-1776 free base
|
SGI-1776 free base is a novel ATP competitive inhibitor of Pim1 with IC50 of 7 nM in a cell-free assay, 50- and 10-fold selective versus Pim2 and Pim3, also potent to Flt3 and haspin. SGI-1776 induces apoptosis and autophagy. |
- Cell Death Dis, 2024, 15(9):644
- Mar Drugs, 2024, 22(10)444
- Mol Cancer, 2023, 22(1):64
|
|
| S7104 |
AZD1208
|
AZD1208 is a potent, and orally available Pim kinase inhibitor with IC50 of 0.4 nM, 5 nM, and 1.9 nM for Pim1, Pim2, and Pim3 in cell-free assays, respectively. AZD1208 induces autophagy, cell cycle arrest and apoptosis. Phase 1. |
- Nat Commun, 2025, 16(1):256
- Angiogenesis, 2024, 10.1007/s10456-024-09906-y
- Cell Death Dis, 2024, 15(4):274
|
|
| S7985 |
PIM447 (LGH447) Hydrochloride
|
PIM447 (LGH447) Hydrochloride is a novel pan-PIM kinase inhibitor with Ki values of 6 pM, 18 pM, 9 pM for PIM1, PIM2, PIM3 respectively. It also inhibits GSK3β, PKN1, and PKCτ, but at a significantly lower potency with IC50 between 1 and 5 μM (>105-fold differential relative to the Ki on PIMs). PIM447 induces apoptosis. |
- Oncogene, 2024, 43(6):406-419
- NPJ Precis Oncol, 2024, 8(1):152
- Antiviral Res, 2024, 226:105891
|
|
| S8005 |
SMI-4a
|
SMI-4a (TCS PIM-1 4a) is a potent inhibitor of Pim1 with IC50 of 17 nM, modestly potent to Pim-2, does not significantly inhibit any other serine/threonine- or tyrosine-kinases. |
- Transl Gastroenterol Hepatol, 2024, 9:14
- J Transl Med, 2023, 21(1):452
- Nat Commun, 2022, 13-1:5866
|
|
| S7041 |
CX-6258 HCl
|
CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.
|
- Elife, 2023, 12e69521
- Nat Med, 2020, 10.1038/s41591-020-0926-0
- Nat Commun, 2020, 29;11(1):2086
|
|
| S8800 |
Uzansertib (INCB053914)
|
Uzansertib (INCB053914) is a novel, ATP-competitive, small molecule, pan-inhibitor of PIM kinases with IC50 values of 0.24 nM, 30 nM and 0.12 nM for PIM1, PIM2 and PIM3 respectively in biochemical assays. |
- Antiviral Res, 2024, 226:105891
- Cancer Lett, 2020, 476:23-33
- Fish Shellfish Immunol, 2020, 99:86-98
|
|
| S6774 |
TP-3654
|
TP-3654 is the second-generation PIM inhibitor with Ki values of 5 nM, 239 nM, and 42 nM for PIM-1, PIM-2 and PIM-3, respectively. |
- Cancer Lett, 2025, 613:217496
- PLoS One, 2023, 10.1371/journal.pone.0294065
- Int J Mol Sci, 2021, 22(17)9440
|
|
| S3296 |
Hispidulin
|
Hispidulin (Dinatin), an active natrual ingredient in a number of traditional Chinese medicinal herbs, exhibits inhibitory activity against the oncogenic protein kinase Pim-1 with IC50 of 2.71 μM. Hispidulin induces apoptosis through mitochondrial dysfunction and inhibition of P13k/Akt signalling pathway in HepG2 cancer cells. Hispidulin exerts anti-osteoporotic and bone resorption attenuating effects via activating the AMPK signaling pathway. |
- Evid Based Complement Alternat Med, 2023, 2023:9428241
|
|
| S6497 |
SMI-16a
|
SMI-16a is a selective Pim kinase inhibitor with IC50 values of 150 nM and 20 nM for Pim1 and Pim2 respectively. |
- J Cell Physiol, 2022, 10.1002/jcp.30814
|
|
| E4598 |
MEN1703(SEL24,SEL24-B489)
|
MEN1703(SEL24-B489,SEL24, Pim/flt3 kinase inhibitor SEL24) is a potent, type I, orally active, dual inhibitor of PIM and FLT3-ITD, that exhibits Kd values of 2 nM for PIM1, 2 nM for PIM2 and 3 nM for PIM3, respectively. MEN1703 exhibits its broad therapeutic potential in treatment of acute myeloid leukemia. |
|
|
| S1050 |
TCS PIM-1 1
|
TCS PIM-1 1 (SC 204330) is a potent and selective inhibitor of ATP-competitive Pim-1 kianse with IC50 of 50 nM, shows good selectivity over Pim-2 and MEK1/MEK2 with IC50 > 20000 nM. |
|
|
| E0675 |
Quercetagetin
|
Quercetagetin (6-Hydroxyquercetin), a flavonoid, is a moderately potent and selective, cell-permeable Pim-1 kinase inhibitor with IC50 of 0.34 μM. |
|
|